Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000159180 | SCV000209126 | uncertain significance | not provided | 2023-06-12 | criteria provided, single submitter | clinical testing | Missense variants in this gene are often considered pathogenic (HGMD); In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Ambry Genetics | RCV004668750 | SCV005170279 | uncertain significance | Cardiovascular phenotype | 2024-04-28 | criteria provided, single submitter | clinical testing | The p.S1097T variant (also known as c.3290G>C), located in coding exon 20 of the SOS1 gene, results from a G to C substitution at nucleotide position 3290. The serine at codon 1097 is replaced by threonine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. |
ARUP Laboratories, |
RCV000156973 | SCV000206695 | uncertain significance | Noonan syndrome | 2012-06-15 | no assertion criteria provided | clinical testing |